Cardiorenal Syndrome — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Add metolazone 2.5 mg orally to overcome diuretic resistance
This patient has diuretic resistance with cardiorenal syndrome. The ESC HF Guidelines recommend a sequential nephron blockade strategy: adding a thiazide-type diuretic (metolazone or bendroflumethiazide) to loop diuretics to overcome resistance at the distal convoluted tubule (Class IIa). This combination can produce profound diuresis and requires close monitoring of electrolytes and renal function. Ultrafiltration/CVVH is reserved for refractory fluid overload unresponsive to pharmacological diuretic escalation. Simply increasing the furosemide dose further has diminishing returns due to the ceiling effect.
Reference: ESC (2023): Focused Update on Heart Failure